APA (7th ed.) Citation

Feng, Y., Su, Y., Lin, S., Lin, P., Wu, C., Tung, C., . . . Shiau, A. (2019). Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer. BMC.

Chicago Style (17th ed.) Citation

Feng, Yin-Hsun, Yu-Chu Su, Shuo-Fu Lin, Pey-Ru Lin, Chao-Liang Wu, Chao-Ling Tung, Chien-Feng Li, Gia-Shing Shieh, and Ai-Li Shiau. Oct4 Upregulates Osteopontin via Egr1 and Is Associated with Poor Outcome in Human Lung Cancer. BMC, 2019.

MLA (8th ed.) Citation

Feng, Yin-Hsun, et al. Oct4 Upregulates Osteopontin via Egr1 and Is Associated with Poor Outcome in Human Lung Cancer. BMC, 2019.